BAX
BAX clinical trials: BAXTER INTERNATIONAL INC
Every trial on ClinicalTrials.gov where BAXTER INTERNATIONAL INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 337
- Trials linked
- 80
- As lead sponsor
- 257
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
BAX on the catalyst calendar · BAX registry changes
- Primary completion Dec 23, 2025ActualNo phase registeredNCT07256951Gen 2 Battrode Wear StudyBaxter Healthcare Corporation · Adhesive Wear TimeCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 18, 2025ActualNo phase registeredNCT06056011Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018Baxter Healthcare Corporation · Febrile IllnessCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 12, 2025ActualNo phase registeredNCT07158333Mobile Cardiac Telemetry (MCT) StudyBaxter Healthcare Corporation · HealthyCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 8, 2025ActualNo phase registeredNCT05996809PMCF Study for COSEAL® in Gynecologic SurgeryBaxter Healthcare Corporation · AdhesionCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 27, 2024ActualNo phase registeredNCT05366010Oscillation and Lung Expansion (OLE) Therapy for Treatment of Neuromuscular Disease (NMD) PatientsBaxter Healthcare Corporation · Neuromuscular DiseasesTerminatedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 22, 2025ActualPhase 1NCT06842134A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%EBaxter Healthcare Corporation · Parenteral NutritionCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 22, 2025ActualPhase 1NCT06842121A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates...Baxter Healthcare Corporation · Parenteral NutritionCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 21, 2024ActualPhase 1NCT05567601Doxil/Caelyx BE StudyBaxter Healthcare Corporation · Ovarian CancerCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 30, 2022Sponsor estimatePhase 3NCT06894446Efficacy and Safety of Numeta G13%E Compared to Compounded Parenteral Nutrition in Preterm NeonatesBaxter Healthcare Corporation · Malnutrition, InfantWithdrawnBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2025Sponsor estimateNo phase registeredNCT06937216Evaluation of the Effectiveness of The Volara System Determined by Sputum Movement and ProductionBaxter Healthcare Corporation · Bronchiectasis AdultNot yet recruitingBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2024ActualNo phase registeredNCT05811585PMCF Study for ADEPT® in LaparoscopicGynecologic SurgeryBaxter Healthcare Corporation · AdhesionCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 13, 2023ActualNo phase registeredNCT05330767DermaClose DUKE Fasciotomy and Wound StudyBaxter Healthcare Corporation · Wound of SkinTerminatedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2025Sponsor estimateNo phase registeredNCT06556628Tympanic Thermometer StudyBaxter Healthcare Corporation · Body Temperature ChangesUnknown statusBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 31, 2025Sponsor estimateNo phase registeredNCT05647161BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open...Baxter Healthcare Corporation · Congenital Heart Disease in ChildrenUnknown statusBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 21, 2024ActualNo phase registeredNCT04648293Starling Registry StudyBaxter Healthcare Corporation · Hemodynamic MonitoringCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 16, 2022ActualPhase 4NCT04555044Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid...Baxter Healthcare Corporation · Essential Fatty Acid Deficiency (EFAD)CompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 14, 2025Sponsor estimateNo phase registeredNCT05729048Starling/CRRT Observational StudyBaxter Healthcare Corporation · Hemodynamic MonitoringWithdrawnBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 28, 2019ActualNo phase registeredNCT03392662Hemopatch Performance Evaluation: A Prospective Observational RegistryBaxter Healthcare Corporation · Dura Mater Nick Cut or TearCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2022ActualPhase 1NCT05309304Cefazolin PK Study 3g vs 2gBaxter Healthcare Corporation · HealthyCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 19, 2021ActualNo phase registeredNCT03463148Validation of a Sensor for Non-Invasive MeasurementsBaxter Healthcare Corporation · CHFCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 9, 2020ActualNo phase registeredNCT04255108Validation of a Sensor for Non-invasive Measurement of Stroke Volume and Cardiac OutputBaxter Healthcare Corporation · Cardiac FailureCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2016ActualPhase 4NCT02476994Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid EmulsionBaxter Healthcare Corporation · Essential Fatty Acid Deficiency (EFAD)TerminatedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 21, 2020ActualNo phase registeredNCT04324593Healthy Volunteer Study to Evaluate the Impact of Various Common Interventions on Venous Pressure Signal Captured by PIVABaxter Healthcare Corporation · Healthy VolunteersTerminatedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 18, 2019ActualPhase 1NCT04155814Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult SubjectsBaxter Healthcare Corporation · BioequivalanceCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 21, 2017ActualNo phase registeredNCT02640235Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue BleedingBaxter Healthcare Corporation · Bleeding ActiveCompletedBAXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 312 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner